Cure8 news brief
This study suggests heated-tobacco products (and possibly e-cigarettes) may increase the risk of endoscopic recurrence after ileocolic resection for Crohn’s disease, which could affect postoperative outcomes and management decisions.
Patients with Crohn’s disease post-ileocolic resection; gastroenterologists and surgeons managing postoperative IBD care; researchers studying tobacco/vaping effects on IBD.
A multicenter international study reported in the August issue of The American Journal of Gastroenterology examined the association between e-cigarette use and postoperative recurrence after ileocolic resection for Crohn’s disease.
Among 937 patients from Italy, Spain, and France, heat-not-burn tobacco use was associated with higher endoscopic recurrence at one year compared with nonsmokers; e-cigarette use showed a similar trend but did not reach statistical significance. The report comes from a journal issue summary provided by the American College of Gastroenterology (ACG).
The news item is a summary of published articles and does not include full trial methods or detailed results beyond the recurrence percentages for heat-not-burn tobacco and the statistical note about e-cigarettes.
If you smoke or use e-cigarettes and have had surgery for Crohn’s disease, this study highlights a potential link between certain heated-tobacco products and higher rates of endoscopic recurrence after ileocolic resection.
The summary does not provide enough detail to change care; discuss smoking and vaping with your gastroenterologist to understand personal risks and cessation options.
The classification and brief are based on the ACG news/journal issue summary; the full article should be reviewed for detailed methods and results. The e-cigarette finding did not reach statistical significance in the reported multivariable analysis.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Postoperative recurrence after ileal resection is common in Crohn’s disease; understanding microbial changes linked to recurrence could help explain mechanisms and guide future biomarker development.
The findings suggest that over three decades more patients receive medical prevention after ileocolic resection — including thiopurines and biologics — and that rates of needing a second surgery have fallen. This matters...
This study suggests that regional differences in how often and how early advanced drugs are used didn’t change 10-year rates of surgery, hospitalization, or progression to complicated Crohn’s disease in this cohort.
